Twenty-seven years of continuous treatment of multiple sclerosis with glatiramer acetate: Long-term efficacy results of the US open-label extension study

Authors
Category Primary study
ConferenceMultiple Sclerosis Journal
Year 2019
This article has no abstract
Epistemonikos ID: 078b4805b71cdbfe7965a0c2a029b78dcb4846bb
First added on: Apr 29, 2026